[Evaluation of the efficacy of ipratropium-fenoterol in the prevention of bronchospasm induced by exertion in comparison with disodium cromoglycate].
D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D001250:Asthma, Exercise-Induced / Q000188:drug therapy* / Q000503:physiopathology; D001286:Atropine Derivatives / Q000627:therapeutic use*; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D004338:Drug Combinations; D004341:Drug Evaluation; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D005280:Fenoterol / Q000627:therapeutic use*; D005540:Forced Expiratory Flow Rates; D005541:Forced Expiratory Volume; D006801:Humans; D009241:Ipratropium / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D001286:Atropine Derivatives; D004338:Drug Combinations; D004983:Ethanolamines; D005280:Fenoterol; D009241:Ipratropium; D004205:Cromolyn Sodium
Valutazione dell'efficacia di iprafen nella prevenzione del broncospasmo indotto dallo sforzo in confronto al disodiocromoglicato.